This morning at our Surg Research Conference, Dr. Paul Romesser discusses translational models to study radiation therapy in gastrointestinal malignancies. #mskcc #SSit #radiationtherapy #GImalignancies

Discussing future biomarkers in #gimalignancies experts ⁦Yelena Y. Janjigian MD⁩ ⁦Diane M. Simeone, MD⁩ ⁦Ghassan Abou-Alfa⁩ ⁦Eileen M O’Reilly⁩ Dr Harding ⁦OncLive SOSS⁩ #stateofscience ⁦@sloan_kettering⁩ ⁦NYU Langone Health⁩

Kicking off tonight’s ⁦OncLive SOSS⁩ ⁦@OncLive⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Tanios Bekaii-Saab, MD⁩ introduces ⁦Daniel Ahn⁩ #gimalignancies #gism

SWOG SL505 had a mixed bag of patients with some borderline resectable says ⁦Dana Cardin, MD⁩ in #pancreaticcancer patients #pancan ⁦OncLive SOSS⁩ #ipc #gimalignancies ⁦Vanderbilt Health⁩ w/chairs ⁦Dr. Cathy Eng⁩ ⁦Dr. jordan berlin⁩ addtl imp study is Alliance A02150

We use this model of dosing from the ReDOS trial ⁦MD Anderson Cancer Center⁩ says ⁦Michael overman⁩ in #metastaticcolorectalcancer with cochair Dr Musher ⁦⁦OncLive SOSS⁩ #stateofscience #gimalignancies ⁦BCMHouston⁩

See the latest #GImalignancies live event from PeerView Yelena Y. Janjigian MD #ASCO24 #MedEd api.lrn.peerview.com/psocial/share/…

Tags trial showing a quality of life benefit in #gastriccancer says ⁦Brandon Smaglo⁩ with cochair Dr Musher ⁦OncLive SOSS⁩ #stateofscience in #gimalignancies ⁦⁦MD Anderson Cancer Center⁩ ⁦BCMHouston⁩

Fabulous group of experts in #gimalignancies led by Dr Mizrahi including Dr Kanwal ⁦Michael overman⁩ ⁦Dr. Shubham Pant⁩ Dr Armaghany ⁦Brandon Smaglo⁩ Dr Nelson Dr Le ⁦MD Anderson Cancer Center⁩ ⁦BCMHouston⁩ ⁦OncLive SOSS⁩ #stateofscience #houston

Jeannie Crowley from ⁦MJH Life Sciences®⁩ kicks off tonight’s ⁦OncLive SOSS⁩ #stateofscience in #Houston with cochair Dr Musher ⁦BCMHouston⁩ ⁦MD Anderson Cancer Center⁩ #gimalignancies

You will receive 3 credits with the participation in this training.

#oncology #gimalignancies #medicaltraining #gastriccancer

LIVE WEBINAR: Register Now & Submit Patient Case

hilfiker-pr.ch/dec2020/

#oncology #gimalignancies #medicaltraining #gastriccancer

In the latest episode of Oncology Overdrive: Mass General Cancer Center’s Aparna Raj Parikh talks with host Shikha Jain MD, FACP about accessibility to screening for #GIoncology and #GImalignancies in the #globalhealthcare space.
Listen now: healio.com/news/hematolog…

Come join us in NY and here what's happening in GI malignancies for 2019! #GI #GI malignancies #NewYork #DAVA

Excellent review by PhD Morelli at #ASCO23 about the landscape of immune bases approaches for #GImalignancies and how novel immune check point inhibitors could provide synergistic effect with PD1/PD-L1 and CTLA-4 inhibitors, without increased toxicity.😁👏
ASCO

All about #PARP inhibitors in #GIMalignancies by Eileen M O’Reilly live from @sloan_kettering at the ibrcaf.com

Shared updates from ASCO in #gimalignancies with OncLive SOSS. Dr. Becerra also presented pancreatic CAR-T and NK cell therapy trials now offered at #BaylorDallas #stateofscience BSWHealth.MED onclive.com/onclive-tv/dr-…

Take Action Now!

Register for December 3 medical training GI Malignancies.

hilfiker-pr.ch/dec2020/

#oncology #gimalignancies #medicaltraining #gastriccancer

In 1 Woche findet die Fortbildung statt 🚀
Jetzt Patientenfall einreichen!

hilfiker-pr.ch/dec2020/

#oncology #gimalignancies #medicaltraining #gastriccancer

Webinar

Today the advanced training GI Malignancies takes place.

Register now: hilfiker-pr.ch/dec2020/

#oncology #gimalignancies #medicaltraining #gastriccancer

Diagnostic Performance of AI-Centered Systems in the Diagnosis and Postoperative Surveillance of Upper #GIMalignancies Using CT Imaging: Review and Meta-Analysis Swathikan Chidambaram rdcu.be/cI722 #VisualAbstract Kelly McMasters, MD, PhD